News
Viking Therapeutics advances its dual GLP-1/GIP obesity drug into Phase 3 trials, entering a $100 billion weight loss market. Applied Digital's $7 billion CoreWeave partnership transforms it into an ...
The breadth of functions for which Palantir's AI platform can be used is a huge opportunity for the company. AppLovin's AI ...
Microsoft Corp. CEO Satya Nadella called Palantir Technologies Inc.'s Forward Deployed Engineer model "fantastic." ...
Jim Cramer believes Palantir could eventually reach a $200 stock price, despite calling it “a little too speculative” for now ...
Palantir Technologies Inc. (NASDAQ:PLTR) is one of the 12 stocks on Jim Cramer’s radar recently. A caller inquired what it ...
Palantir Technologies Inc (NASDAQ:PLTR) shares are hitting new all-time highs on Wednesday. Here's a look at what's fueling ...
18h
MarketBeat on MSNPalantir Stock Hits ATH, But Can the Rally Hold Without Volume?Palantir Technologies Inc. (NASDAQ: PLTR) made a new all-time high (ATH) after a surge of more than 5% after the United ...
Palantir's AI-driven military solutions have proven disruptive, giving it a first-mover advantage in a $2.7 ...
Shares of Palantir Technologies (NASDAQ:PLTR) jumped 5.32% over the past five trading sessions, largely fueled by a rally in ...
As of this writing, Palantir Technologies (NASDAQ: PLTR) holds the top year-to-date performance of any stock within the ...
20h
Zacks Investment Research on MSNInvestors Heavily Search Palantir Technologies Inc. (PLTR): Here is What You Need to KnowPalantir Technologies Inc. (PLTR) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to ...
The company is securing more contracts under the Trump administration, and there seems to be rising investor confidence that Palantir will gain from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results